1211 related articles for article (PubMed ID: 12612581)
1. An essential role for Scurfin in CD4+CD25+ T regulatory cells.
Khattri R; Cox T; Yasayko SA; Ramsdell F
Nat Immunol; 2003 Apr; 4(4):337-42. PubMed ID: 12612581
[TBL] [Abstract][Full Text] [Related]
2. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
[TBL] [Abstract][Full Text] [Related]
3. CD25(+)CD4(+) regulatory T cells exert in vitro suppressive activity independent of CTLA-4.
Kataoka H; Takahashi S; Takase K; Yamasaki S; Yokosuka T; Koike T; Saito T
Int Immunol; 2005 Apr; 17(4):421-7. PubMed ID: 15724061
[TBL] [Abstract][Full Text] [Related]
4. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
[TBL] [Abstract][Full Text] [Related]
5. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
6. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Fontenot JD; Gavin MA; Rudensky AY
Nat Immunol; 2003 Apr; 4(4):330-6. PubMed ID: 12612578
[TBL] [Abstract][Full Text] [Related]
7. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
8. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.
Makita S; Kanai T; Oshima S; Uraushihara K; Totsuka T; Sawada T; Nakamura T; Koganei K; Fukushima T; Watanabe M
J Immunol; 2004 Sep; 173(5):3119-30. PubMed ID: 15322172
[TBL] [Abstract][Full Text] [Related]
9. The origin of thymic CD4+CD25+ regulatory T cells and their co-stimulatory requirements are determined after elimination of recirculating peripheral CD4+ cells.
Zhan Y; Bourges D; Dromey JA; Harrison LC; Lew AM
Int Immunol; 2007 Apr; 19(4):455-63. PubMed ID: 17314081
[TBL] [Abstract][Full Text] [Related]
10. [T cell mediated immunoregulation and autoimmune disease].
Takahashi T; Sakaguchi S
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2331-5. PubMed ID: 12518457
[No Abstract] [Full Text] [Related]
11. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo.
Taylor MD; LeGoff L; Harris A; Malone E; Allen JE; Maizels RM
J Immunol; 2005 Apr; 174(8):4924-33. PubMed ID: 15814720
[TBL] [Abstract][Full Text] [Related]
12. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.
Yagi H; Nomura T; Nakamura K; Yamazaki S; Kitawaki T; Hori S; Maeda M; Onodera M; Uchiyama T; Fujii S; Sakaguchi S
Int Immunol; 2004 Nov; 16(11):1643-56. PubMed ID: 15466453
[TBL] [Abstract][Full Text] [Related]
13. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.
Hultkrantz S; Ostman S; Telemo E
Immunology; 2005 Nov; 116(3):362-72. PubMed ID: 16236126
[TBL] [Abstract][Full Text] [Related]
14. Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.
Zelenay S; Lopes-Carvalho T; Caramalho I; Moraes-Fontes MF; Rebelo M; Demengeot J
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4091-6. PubMed ID: 15753306
[TBL] [Abstract][Full Text] [Related]
15. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.
Zheng SG; Wang JH; Stohl W; Kim KS; Gray JD; Horwitz DA
J Immunol; 2006 Mar; 176(6):3321-9. PubMed ID: 16517699
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
19. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells.
Bopp T; Palmetshofer A; Serfling E; Heib V; Schmitt S; Richter C; Klein M; Schild H; Schmitt E; Stassen M
J Exp Med; 2005 Jan; 201(2):181-7. PubMed ID: 15657288
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
